Aimei Health Technology Co., Ltd.
Searching since IPO 2023-12-05- CIK 1979005
- AFJK
- IPO 2023-12-05
- $12.5M trust
- 123 filings
- IPO Size
- $69M
- raised at the IPO
- Trust
- $12.5M
- as of 2026-06-30
- Current Status
- Unit Split
- from its latest filing
- IPO Year
- 2023
- year it listed
Filings, by quarter
123 filings over 15 quarters; violet bars carry a milestone
- 23 Q2: 2 filings
- 23 Q3: 8 filings
- 23 Q4: 19 filings
- 24 Q1: 8 filings
- 24 Q2: 4 filings
- 24 Q3: 1 filing
- 24 Q4: 10 filings
- 25 Q1: 18 filings
- 25 Q2: 7 filings
- 25 Q3: 9 filings
- 25 Q4: 11 filings
- 26 Q1: 5 filings
- 26 Q2: 9 filings
- 26 Q3: 9 filings
- 26 Q4: 3 filings
- S-1 filed 23 Q2
- IPO 23 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Aimei Health Technology Co., Ltd. is a blank-check company seeking a business combination. Its intended focus is small-cap healthcare innovation businesses, particularly in biopharmaceuticals, medical technology/devices, diagnostics and related services.
Investment Focus
Healthcare, Biopharmaceuticals, Technology
Geographic Focus
North America, Europe, Asia Pacific
Key Information
As the filings state it
- IPO Date
- 2023-12-05
- Total Redemptions
- $76.1M
- SIC
- 6770
- SPAC Ticker
- AFJK
Stock Performance
AFJKUTrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2023-12-05 | $10.14 | |
| Current Price | 2026-10-23 | $12.01 | +18% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team includes CEO Juan Fernandez Pascual, with automotive and industrial leadership experience and prior SPAC COO experience, and CFO Heung Ming Wong, with extensive finance, accounting and public-company director experience. Its director nominees bring experience in accounting, auditing, healthcare, business operations, private equity, and real estate.